Join the RSV Vaccine, Pref A-Pref B, Recombinant group to help and get support from people like you.
RSV Vaccine, Pref A-Pref B, Recombinant News
Most Moms-to-Be Interested in RSV Vaccination During Pregnancy
THURSDAY, April 25, 2024 – More than half of women who are pregnant or planning to become pregnant are very likely to get vaccinated against respiratory syncytial virus (RSV) during pregnancy,...
Most Seniors With RSV-Linked Hospitalization Are Aged ≥75
FRIDAY, Oct. 6, 2023 – Most respiratory syncytial virus (RSV)-associated hospitalizations among seniors aged ≥60 years occur in those aged ≥75 years, and although RSV is less common among seniors, it...
Just 23% of U.S. Adults 'Definitely' Plan to Get New COVID Shot
WEDNESDAY, Sept. 27, 2023 – Just 23% of American adults say they 'definitely' will get the new COVID-19 vaccine, while another 23% say they will 'probably' get it, according to a new poll, which...
It's Time to Start Preparing Against Flu, RSV & COVID-19
FRIDAY, Sept. 15, 2023 – Kids are back in school and it’s time to think about viruses, for both yourself and them. It could be an early flu season in the United States, if what happened in the Sou...
U.S. FDA Approves Abrysvo, Pfizer’s Vaccine for the Prevention of Respiratory Syncytial Virus (RSV) in Infants Through Active Immunization of Pregnant Individuals 32-36 Weeks of Gestational Age
NEW YORK--(BUSINESS WIRE) August 21, 2023 – Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved Abrysvo™ (Respiratory Syncytial Virus Vaccine), the c...
Vaccines Against Shingles, Pneumonia May Also Lower Your Alzheimer's Risk
MONDAY, Aug. 21, 2023 – Certain adult vaccines, including shingles and pneumonia shots, may also help seniors fight off Alzheimer's disease, new research reveals. Prior vaccination with the shingles...
Most Infants Hospitalized With RSV Were Otherwise Healthy, Study Finds
TUESDAY, Aug. 15, 2023 – As experts begin preparing for another season of viruses, they now know that even healthy infants with no underlying health issues are at risk for severe respiratory...
Education on Approval Process May Increase Acceptance of New RSV Vaccines
MONDAY, Aug. 14, 2023 – People are more likely to recommend that a pregnant family member or friend get vaccinated to protect the infant from respiratory syncytial virus (RSV) if they are shown...
FDA Approves Abrysvo (respiratory syncytial virus vaccine) for the Prevention of Respiratory Syncytial Virus (RSV) in Older Adults
NEW YORK--(BUSINESS WIRE) May 31, 2023 – Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved Abrysvo™ (Respiratory Syncytial Virus Vaccine), the c...
FDA Approves Arexvy (respiratory syncytial virus vaccine, adjuvanted) Respiratory Syncytial Virus (RSV) Vaccine for Older Adults
May 3, 2023 – GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Arexvy (respiratory syncytial virus vaccine, adjuvanted) for the prevention of lower...
Ask a question
To post your own question to this support group, sign in or create an account.